Acceptance rate 46%
Time to first decision 6 months*
Time to decision with review 50 days*

*Approximate number of days

**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.


ACTA Pharmaceutica Sciencia 2020 , Vol 58 , Num 4
Molecular Drug Design and Docking Study of Novel N- substituted Celecoxib Derivatives as Selective Cyclooxygenase-2 Inhibitors
Mohammed Ezzat 1 Basma Abd Razik 2
1 College of Education for Women, University of Anbar, Department of Chemistry, Ramadi, Iraq, 2 College of Pharmacy, Mustansiriyah University, Department of Pharmaceutical Chemistry, Baghdad, Iraq DOI : 10.23893/1307-2080.APS.05823

Summary

Istanbul Medipol University